Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             45 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison Eldefrawy, Ahmed
2013
31 5 p. 576-580
5 p.
artikel
2 A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer Lin, Jianqing
2013
31 5 p. 581-588
8 p.
artikel
3 A prospective randomized multicenter study of Turkish Society of Urooncology comparing two different mechanical bowel preparation methods for radical cystectomy Aslan, Guven
2013
31 5 p. 664-670
7 p.
artikel
4 A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry Montironi, Rodolfo
2013
31 5 p. 557-565
9 p.
artikel
5 A risk-adapted strategy of radiotherapy or cisplatin-based chemotherapy in stage II seminoma Domont, Julien
2013
31 5 p. 697-705
9 p.
artikel
6 Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction Kusuda, Yuji
2013
31 5 p. 615-621
7 p.
artikel
7 Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis Vinarskaja, Anna
2013
31 5 p. 622-627
6 p.
artikel
8 Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer Salami, Simpa S.
2013
31 5 p. 566-571
6 p.
artikel
9 Commentary on “A phase II study of oportuzumab monatox: An immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin.” Kowalski M, Guindon J, Brazas L, Moore C, Entwistle J, Cizeau J, Jewett MA, MacDonald GC See, William A.
2013
31 5 p. 714-
1 p.
artikel
10 Commentary on “Carboplatin based induction chemotherapy for nonorgan confined bladder cancer—a reasonable alternative for cisplatin unfit patients?” Mertens LS, Meijer RP, Kerst JM, Bergman AM, van Tinteren H, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Kamat, Ashish M.
2013
31 5 p. 716-717
2 p.
artikel
11 Commentary on “Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma.” Wong YN, Litwin S, Vaughn D, Cohen S, Plimack ER, Lee J, Song W, Dabrow M, Brody M, Tuttle H, Hudes G, University of Pennsylvania, Philadelphia, PA See, William A.
2013
31 5 p. 719-
1 p.
artikel
12 Commentary on “Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition.” Ros MM, Bueno-de-Mesquita HB, Kampman E, Aben KK, Büchner FL, Jansen EH, van Gils CH, Egevad L, Overvad K, Tjønneland A, Roswall N, Boutron-Ruault MC, Kvaskoff M, Perquier F, Kaaks R, Chang-Claude J, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Dilis V, Palli D, Pala V, Sacerdote C, Tumino R, Panico S, Peeters PH, Gram IT, Skeie G, Huerta JM, Barricarte A, Quirós JR, Sánchez MJ, Buckland G, Larrañaga N, Ehrnström R, Wallström P, Ljungberg B, Hallmans G, Key TJ, Allen NE, Khaw KT, Wareham N, Brennan P, Riboli E, Kiemeney LA, National Institute for Public Health and the Environment, Bilthoven, Netherlands Kamat, Ashish M.
2013
31 5 p. 714-715
2 p.
artikel
13 Commentary on “Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.” Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. Department of Urology, Central Hospital of Bolzano, Bolzano, Italy See, William A.
2013
31 5 p. 718-719
2 p.
artikel
14 Commentary on “Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.” Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia Kamat, Ashish M.
2013
31 5 p. 716-
1 p.
artikel
15 Commentary on “Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.” Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada Kamat, Ashish M.
2013
31 5 p. 717-718
2 p.
artikel
16 Commentary on “The clinical epidemiology of urachal carcinoma: Results of a large, population based study.” Bruins HM, Visser O, Ploeg M, Hulsbergen-van de Kaa CA, Kiemeney LA, Witjes JA, Department of Urology, Radboud University Medical Centre, Utrecht, The Netherlands See, William A.
2013
31 5 p. 720-
1 p.
artikel
17 Commentary on “The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature.” Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria Kamat, Ashish M.
2013
31 5 p. 715-716
2 p.
artikel
18 Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness Lose, Felicity
2013
31 5 p. 635-643
9 p.
artikel
19 Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients Nepple, Kenneth G.
2013
31 5 p. 601-606
6 p.
artikel
20 Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer Langenhuijsen, Johan F.
2013
31 5 p. 549-556
8 p.
artikel
21 Dynamic sentinel lymph node biopsy as the new paradigm for the management of penile cancer Yeung, Lawrence L.
2013
31 5 p. 693-696
4 p.
artikel
22 Editorial Board 2013
31 5 p. iv-
1 p.
artikel
23 Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry Yang, Bo
2013
31 5 p. 628-634
7 p.
artikel
24 Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: Implications for novel intraoperative PSMA-based fluorescent imaging techniques Chaux, Alcides
2013
31 5 p. 572-575
4 p.
artikel
25 Inflammation and prostate cancer Dal Moro, Fabrizio
2013
31 5 p. 712-
1 p.
artikel
26 Information for Authors 2013
31 5 p. IBC-
1 p.
artikel
27 Insulin-like growth factor pathway: A link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? Aggarwal, Rahul R.
2013
31 5 p. 522-530
9 p.
artikel
28 Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers Namdarian, Benjamin
2013
31 5 p. 649-655
7 p.
artikel
29 Masthead 2013
31 5 p. IFC-
1 p.
artikel
30 Molecular markers of kidney injury Lane, Brian R.
2013
31 5 p. 682-685
4 p.
artikel
31 Non-bladder cancer mortality in patients with urothelial cancer of the bladder Scosyrev, Emil
2013
31 5 p. 656-663
8 p.
artikel
32 Phase II study of biweekly gemcitabine as first line therapy in CIS of the bladder: What does an aborted trial tell us? Gontero, Paolo
2013
31 5 p. 671-675
5 p.
artikel
33 Positive margins after radical prostatectomy: Implications for failure and role of adjuvant treatment Swanson, Gregory P.
2013
31 5 p. 531-541
11 p.
artikel
34 Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery Sciarra, Alessandro
2013
31 5 p. 607-614
8 p.
artikel
35 Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy Pierorazio, Phillip M.
2013
31 5 p. 589-594
6 p.
artikel
36 Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: The Cleveland Clinic experience with 3 years follow-up Yang, Bo
2013
31 5 p. 686-692
7 p.
artikel
37 Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer Oh, Jong Jin
2013
31 5 p. 595-600
6 p.
artikel
38 Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study Zhu, Yao
2013
31 5 p. 706-711
6 p.
artikel
39 Serum carcino-embryonic antigen (CEA) and its possible use as tumor marker for secondary tumors in urinary intestinal reservoirs Loeser, Andreas
2013
31 5 p. 644-648
5 p.
artikel
40 Survey Section Editorial Board 2013
31 5 p. 713-
1 p.
artikel
41 Table of Contents 2013
31 5 p. v-viii
nvt p.
artikel
42 The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma Woodruff, Daniel Y.
2013
31 5 p. 517-521
5 p.
artikel
43 Transurethral resection biopsy as part of a saturation biopsy protocol: A cohort study and review of the literature Yates, David R.
2013
31 5 p. 542-548
7 p.
artikel
44 Update in the surgical principles and therapeutic outcomes of inguinal lymph node dissection for penile cancer Ercole, Cesar E.
2013
31 5 p. 505-516
12 p.
artikel
45 Urothelial carcinoma at the uretero-enteric junction: Multi-center evaluation of oncologic outcomes after radical nephroureterectomy Youssef, Ramy F.
2013
31 5 p. 676-681
6 p.
artikel
                             45 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland